By Kelly Cloonan
Shares of Phathom Pharmaceuticals fell after the company said Chief Executive Officer Terrie Curran has resigned and will be succeeded by SaNOtize's Steven Basta.
The stock declined 22% to $4.88 on Tuesday, bringing its fall over the last 12 months to 54%.
Phathom said Curran has resigned from her roles as president, CEO and a member of the board for personal reasons.
Basta joins the Florham Park, N.J., biopharmaceutical company as president, CEO and a director, the company said.
Basta previously led SaNOtize, an anti-infective therapies company.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 01, 2025 15:24 ET (19:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.